Allevo helps pharmaceutical group Dr. Max România (former A&D Pharma) get full control over its business flows
Using Allevo’s solution qPI-TIPc and Microsoft BizTalk Server, Dr. Max România (former A&D Pharma) enjoys the advantages of a centralized management of financial operations.

Allevo, in a joint effort with Dr. Max România (former A&D Pharma) IT and business employees, as well as Microsoft BizTalk Server-Certified Professionals, has reached the final implementation stage of its qPayIntegrator-TIPc (qPI-TIPc) solution in the pharmaceutical company in 2012.
The solution, designed to complement Dr. Max România (former A&D Pharma) ERP systems, provides them with a single interface for the payments management of all the group’s entities, monitoring and reporting, regardless of the bank they are using.
By providing centralized management of financial operations, Allevo’s qPI-TIPc solution enables Dr. Max România (former A&D Pharma) to mitigate operational risks due to duplicate payments detection, eradication of human errors or fraud in bank’s interfaces access. qPI-TIPc is able to process domestic and international payment instructions – from the initiation to the reconciliation with the bank statement, to generate relevant reports and statistics by having a single view of all payment instructions in one application window. Using Microsoft BizTalk Server, the platform benefits from the high performance, scalability and reliability this technology has to offer.
“Providing integrated payment solutions is essential in lowering risk and providing efficiency and reliability in the financial supply chain,” said Colin Kerr, industry solutions manager, worldwide financial services at Microsoft. “Corporate treasuries and banks around the world are benefiting from the performance and low cost of ownership of BizTalk Server for financial messaging. We are excited to support Allevo’s development of solutions that simplify payments management and operations.”
“By implementing and using qPI-TIPc solution, Dr. Max România (former A&D Pharma) will not only gain full control of its business flows and financial operations, but will also benefit from strong operational risk containment for its business lines”, says Dan Anghelescu, Operations Director Allevo.

